Abstract:<span class="a-plus-plus abstract-section id-a-sec1"><h3 class="a-plus-plus">Background</h3><p class="a-plus-plus">Cancer-associated fibroblasts (CAFs) are recruited to the tumor microenvironment (TME) and are critical drivers of breast cancer (BC) malignancy. Circulating tumor cells (CTCs) travel through hematogenous routes to establish metastases. CTCs circulate both individually and, more rarely, in clusters with other cell types. Clusters of CTCs have higher metastatic potential than single CTCs. Previously, we identified circulating CAFs (cCAFs) in patients with BC and found that while healthy donors had no CTCs or cCAFs, both were present in most Stage IV patients. cCAFs circulate individually, as cCAF–cCAF homotypic clusters, and in heterotypic clusters with CTCs.</p></span><span class="a-plus-plus abstract-section id-a-sec2"><h3 class="a-plus-plus">Methods</h3><p class="a-plus-plus">In this study, we evaluate CTCs, cCAFs, and heterotypic cCAF-CTC clusters in patients with stage I–IV BC. We evaluate the association of heterotypic clusters with BC disease progression and metastasis in a spontaneous mouse model. Using previously established primary BC and CAF cell lines, we examine the metastatic propensity of heterotypic cCAF-CTC clusters in orthotopic and tail vein xenograft mouse models of BC. Using an in vitro clustering assay, we determine factors that may be involved in clustering between CAF and BC cells.</p></span><span class="a-plus-plus abstract-section id-a-sec3"><h3 class="a-plus-plus">Results</h3><p class="a-plus-plus">We report that the dissemination of CTCs, cCAFs, and clusters is an early event in BC progression, and we find these clusters in all clinical stages of BC. Furthermore, cCAFs-CTC heterotypic clusters have a higher metastatic potential than homotypic CTC clusters in vivo. We also demonstrate that the adhesion and stemness marker CD44, found on a subset of CTCs and CAF cells, is involved in heterotypic clustering of these cells.</p></span><span class="a-plus-plus abstract-section id-a-sec4"><h3 class="a-plus-plus">Conclusion</h3><p class="a-plus-plus">We identify a novel subset of circulating tumor cell clusters that are enriched with stromal CAF cells in BC patient blood and preclinical mouse models of BC metastasis. Our data suggest that clustering of CTCs with cCAFs augments their metastatic potential and that CD44 might be an important mediator of heterotypic clustering of cCAFs and BC cells.</p></span>

Proportion of circulating tumor cell clusters increases during cancer metastasis

Circulating tumor cells occur nonuniformly monitored by in vivo flow cytometry

A narrative review of circulating tumor cells clusters: A key morphology of cancer cells in circulation promote hematogenous metastasis

Better together: circulating tumor cell clustering in metastatic cancer

Key Characteristics of Circulating Tumor Cell Clusters and Implications for Cancer Metastases

Single-cell metabolic fingerprints discover a cluster of circulating tumor cells with distinct metastatic potential

Circulating tumor cell clusters: Insights into tumour dissemination and metastasis

Circulating Tumour Cell Clusters: Isolation, Biological Significance and Therapeutic Implications

Multi-omic features and clustering phenotypes of circulating tumor cells associated with metastasis and clinical outcomes

Clusters of circulating tumor cells traverse capillary-sized vessels

Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis

Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis

Real-Time Monitoring Of Rare Circulating Hepatocellular Carcinoma Cells In An Orthotopic Model By In Vivo Flow Cytometry Assesses Resection On Metastasis

Bring along your friends: Homotypic and heterotypic circulating tumor cell clustering to accelerate metastasis

Data from Real-Time Monitoring of Rare Circulating Hepatocellular Carcinoma Cells in an Orthotopic Model by <i>in Vivo</i> Flow Cytometry Assesses Resection on Metastasis

Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer

Data from Real-Time Monitoring of Rare Circulating Hepatocellular Carcinoma Cells in an Orthotopic Model by <i>In Vivo</i> Flow Cytometry Assesses Resection on Metastasis

EMT Status of Circulating Breast Cancer Cells and Impact of Fluidic Shear Stress

Prospective Assessment of the Prognostic Value of Circulating Tumor Cells and Their Clusters in Patients with Advanced-Stage Breast Cancer.

Circulating Tumor Cell Clusters: United We Stand Divided We Fall

In Vivo Flow Cytometry Visualizes the Effects of Tumor Resection on Metastasis by Real-Time Monitoring of Rare Circulating Cancer Cells